Research Groups

Early Detection and Prevention - Prevention and Implementation Group

Previous Publications - All Publications 2016-2012

1. Arrossi S., Thouyaret L., Laudi R., Marin O., Ramirez J., Paolino M., Herrero R., Campanera A. (2015) Implementation of HPV-testing for cervical cancer screening in programmatic contexts: The Jujuy demonstration project in Argentina Int.J Cancer; 137(7):1709-1718. PMID: 25807897

2. Kreimer A.R., Struyf F., Del Rosario-Raymundo M.R., Hildesheim A., Skinner S.R., Wacholder S., Garland S.M., Herrero R., David M.P., Wheeler C.M. (2015) Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials Lancet Oncol.; 16(7):775-786. PMID: 26071347

3. Quesada P., Whitby D., Benavente Y., Miley W., Labo N., Chichareon S., Trong N., Shin H.R., Anh P.T., Thomas J., Matos E., Herrero R., Munoz N., Molano M., Franceschi S., de Sanjose S. (2015) Hepatitis C virus seroprevalence in the general female population from 8 countries J Clin.Virol.; 89-93. PMID: 26071344

4. Park M.K., Park J.Y., Nicolas G., Paik H.Y., Kim J., Slimani N. (2015) Adapting a standardised international 24 h dietary recall methodology (GloboDiet software) for research and dietary surveillance in Korea Br.J Nutr.; 113(11):1810-1818. PMID: 25899045

5. Lowy D.R., Herrero R., Hildesheim A., =Participants in the IARC/NCI workshop on Primary Endpoints for Prophylactic HPV Vaccine Trials (2015) Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging Lancet Oncol.; 16(5):e226-e233. PMID: 25943067

6. Herrero R., Gonzalez P., Markowitz L.E. (2015) Present status of human papillomavirus vaccine development and implementation Lancet Oncol.; 16(5):e206-e216. PMID: 25943065

7. Gonzalez P., Hildesheim A., Herrero R., Katki H., Wacholder S., Porras C., Safaeian M., Jimenez S., Darragh T.M., Cortes B., Befano B., Schiffman M., Carvajal L., Palefsky J., Schiller J., Ocampo R., Schussler J., Lowy D., Guillen D., Stoler M.H., Quint W., Morales J., Avila C., Rodriguez A.C., Kreimer A.R. (2015) Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica Vaccine; 33(18):2141-2151. PMID: 25796338

8. Conway D.I., Brenner D.R., McMahon A.D., Macpherson L.M., Agudo A., Ahrens W., Bosetti C., Brenner H., Castellsague X., Chen C., Curado M.P., Curioni O.A., Dal Maso L., Daudt A.W., de Gois Filho J.F., D'Souza G., Edefonti V., Fabianova E., Fernandez L., Franceschi S., Gillison M., Hayes R.B., Healy C.M., Herrero R., Holcatova I., Jayaprakash V., Kelsey K., Kjaerheim K., Koifman S., La Vecchia C., Lagiou P., Lazarus P., Levi F., Lissowska J., Luce D., Macfarlane T.V., Mates D., Matos E., McClean M., Menezes A.M., Menvielle G., Merletti F., Morgenstern H., Moysich K., Muller H., Muscat J., Olshan A.F., Purdue M.P., Ramroth H., Richiardi L., Rudnai P., Schantz S., Schwartz S.M., Shangina O., Simonato L., Smith E., Stucker I., Sturgis E.M., Szeszenia-Dabrowska N., Talamini R., Thomson P., Vaughan T.L., Wei Q., Winn D.M., Wunsch-Filho V., Yu G.P., Zhang Z.F., Zheng T., Znaor A., Boffetta P., Chuang S.C., Ghodrat M., Amy Lee Y.C., Hashibe M., Brennan P. (2015) Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries International journal of cancer; 136(5):1125-1139. PMID: 24996155

9. Arrossi S., Thouyaret L., Herrero R., Campanera A., Magdaleno A., Cuberli M., Barletta P., Laudi R., Orellana L. (2015) Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial Lancet Glob.Health; 3(2):e85-e94. PMID: 25617202

10. Toporcov T.N., Znaor A., Zhang Z.F., Yu G.P., Winn D.M., Wei Q., Vilensky M., Vaughan T., Thomson P., Talamini R., Szeszenia-Dabrowska N., Sturgis E.M., Smith E., Shangina O., Schwartz S.M., Schantz S., Rudnai P., Richiardi L., Ramroth H., Purdue M.P., Olshan A.F., Eluf-Neto J., Muscat J., Moyses R.A., Morgenstern H., Menezes A., McClean M., Matsuo K., Mates D., Macfarlane T.V., Lissowska J., Levi F., Lazarus P., La Vecchia C., Lagiou P., Koifman S., Kjaerheim K., Kelsey K., Holcatova I., Herrero R., Healy C., Hayes R.B., Franceschi S., Fernandez L., Fabianova E., Daudt A.W., Curioni O.A., Maso L.D., Curado M.P., Conway D.I., Chen C., Castellsague X., Canova C., Cadoni G., Brennan P., Boccia S., Antunes J.L., Ahrens W., Agudo A., Boffetta P., Hashibe M., Lee Y.C., Filho V.W. (2015) Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium Int.J Epidemiol.; 44(1):169-185. PMID: 25613428

11. de Batlle J., Ferrari P., Chajes V., Park J.Y., Slimani N., McKenzie F., Overvad K., Roswall N., Tjonneland A., Boutron-Ruault M.C., Clavel-Chapelon F., Fagherazzi G., Katzke V., Kaaks R., Bergmann M.M., Trichopoulou A., Lagiou P., Trichopoulos D., Palli D., Sieri S., Panico S., Tumino R., Vineis P., Bueno-de-Mesquita H.B., Peeters P.H., Hjartaker A., Engeset D., Weiderpass E., Sanchez S., Travier N., Sanchez M.J., Amiano P., Chirlaque M.D., Barricarte Gurrea A., Khaw K.T., Key T.J., Bradbury K.E., Ericson U., Sonestedt E., Van Guelpen B., Schneede J., Riboli E., Romieu I. (2015) Dietary folate intake and breast cancer risk: European prospective investigation into cancer and nutrition Journal of the National Cancer Institute; 107(1):367. PMID: 25505228

12. Porras C., Hildesheim A., Gonzalez P., Schiffman M., Rodriguez A.C., Wacholder S., Jimenez S., Quint W., Guillen D., Kreimer A.R., Herrero R. (2015) Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing Journal of the National Cancer Institute; 107(1):400. PMID: 25479804

13. Antilla A., Arbyn M, De Vuyst H., Dillner J., Dillner L., Franceschi S., Patnick J., Ronco G., Segnan N., Suonio E., Tornberg S., von Karsa L. (2015) European guidelines for quality assurance in cervical cancer screening ; .

14. Almonte M., Ferreccio C., Luciani S., Gonzales M., Delgado J.M., Santos C., Alvarez M., Cuzick J., Sasieni P. (2015) Visual Inspection after Acetic Acid (VIA) Is Highly Heterogeneous in Primary Cervical Screening in Amazonian Peru PLoS.One.; 10(1):e0115355. PMID: 25635965

15. Panagiotou O.A., Befano B.L., Gonzalez P., Rodriguez A.C., Herrero R., Schiller J.T., Kreimer A.R., Schiffman M., Hildesheim A., Wilcox A.J., Wacholder S. (2015) Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial British medical journal; h4358. PMID: 26346155

16. Lang Kuhs K.A., Gonzalez P., Rodriguez A.C., Van Doorn L.J., Schiffman M., Struijk L., Chen S., Quint W., Lowy D.R., Porras C., DelVecchio C., Jimenez S., Safaeian M., Schiller J.T., Wacholder S., Herrero R., Hildesheim A., Kreimer A.R. (2014) Reduced Prevalence of Vulvar HPV16/18 Infection Among Women Who Received the HPV16/18 Bivalent Vaccine: A Nested Analysis Within the Costa Rica Vaccine Trial Journal of infectious diseases; 210(12):1890-1899. PMID: 24958910

17. Herrero R., Park J.Y., Forman D. (2014) The fight against gastric cancer - the IARC Working Group report Best.Pract.Res Clin Gastroenterol; 28(6):1107-1114. PMID: 25439075

18. Combes J.D., Pawlita M., Waterboer T., Hammouda D., Rajkumar T., Vanhems P., Snijders P., Herrero R., Franceschi S., Clifford G. (2014) Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer International journal of cancer; 135(10):2453-2461. PMID: 24729277

19. Park J.Y., von Karsa L., Herrero R. (2014) Prevention strategies for gastric cancer: a global perspective Clin Endosc.; 47(6):478-489. PMID: 25505712

20. Bedoya A.M., Tate D.J., Baena A., Cordoba C.M., Borrero M., Pareja R., Rojas F., Patterson J.R., Herrero R., Zea A.H., Sanchez G.I. (2014) Immunosuppression in cervical cancer with special reference to arginase activity Gynecol.Oncol; 135(1):74-80. PMID: 25084511

21. Campos N.G., Burger E.A., Sy S., Sharma M., Schiffman M., Rodriguez A.C., Hildesheim A., Herrero R., Kim J.J. (2014) An updated natural history model of cervical cancer: derivation of model parameters American journal of epidemiology; 180(5):545-555. PMID: 25081182

22. Herrero R., Parsonnet J., Greenberg E.R. (2014) Prevention of gastric cancer JAMA; 312(12):1197-1198. PMID: 25247512

23. Lang Kuhs K.A., Porras C., Schiller J.T., Rodriguez A.C., Schiffman M., Gonzalez P., Wacholder S., Ghosh A., Li Y., Lowy D.R., Kreimer A.R., Poncelet S., Schussler J., Quint W., Van Doorn L.J., Sherman M.E., Sidawy M., Herrero R., Hildesheim A., Safaeian M. (2014) Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates Am.J.Epidemiol.; 180(6):599-607. PMID: 25139208

24. Rollan A., Arab J.P., Camargo M.C., Candia R., Harris P., Ferreccio C., Rabkin C.S., Gana J.C., Cortes P., Herrero R., Duran L., Garcia A., Toledo C., Espino A., Lustig N., Sarfatis A., Figueroa C., Torres J., Riquelme A. (2014) Management of Helicobacter pylori infection in Latin America: A Delphi technique-based consensus World Journal of Gastroenterology : WJG; 20(31):10969-10983. PMID: 25152601

25. Lazcano-Ponce E., Stanley M., Munoz N., Torres L., Cruz-Valdez A., Salmeron J., Rojas R., Herrero R., Hernandez-Avila M. (2014) Overcoming barriers to HPV vaccination: Non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months Vaccine; 32(6):725-732. PMID: 24355090

26. Ronco G., Dillner J., Elfstrom K.M., Tunesi S., Snijders P.J., Arbyn M., Kitchener H., Segnan N., Gilham C., Giorgi-Rossi P., Berkhof J., Peto J., Meijer C.J. (2014) Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials Lancet; 383(9916):524-532. PMID: 24192252

27. Leoncini E., Ricciardi W., Cadoni G., Arzani D., Petrelli L., Paludetti G., Brennan P., Luce D., Stucker I., Matsuo K., Talamini R., La Vecchia C., Olshan A.F., Winn D.M., Herrero R., Franceschi S., Castellsague X., Muscat J., Morgenstern H., Zhang Z.F., Levi F., Dal Maso L., Kelsey K., McClean M., Vaughan T.L., Lazarus P., Purdue M.P., Hayes R.B., Chen C., Schwartz S.M., Shangina O., Koifman S., Ahrens W., Matos E., Lagiou P., Lissowska J., Szeszenia-Dabrowska N., Fernandez L., Menezes A., Agudo A., Daudt A.W., Richiardi L., Kjaerheim K., Mates D., Betka J., Yu G.P., Schantz S., Simonato L., Brenner H., Conway D.I., Macfarlane T.V., Thomson P., Fabianova E., Znaor A., Rudnai P., Healy C., Boffetta P., Chuang S.C., Lee Y.C., Hashibe M., Boccia S. (2014) Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium European journal of epidemiology; 29(1):35-48. PMID: 24271556

28. Chen A.A., Heideman D.A., Boon D., Chen Z., Burk R.D., De Vuyst H., Gheit T., Snijders P.J., Tommasino M., Franceschi S., Clifford G.M. (2014) Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer Virology; 356-362. PMID: 24314666

29. Robbins H.A., Kemp T.J., Porras C., Rodriguez A.C., Schiffman M., Wacholder S., Gonzalez P., Schiller J., Lowy D., Poncelet S., Esser M., Matys K., Hildesheim A., Pinto L.A., Herrero R., Safaeian M. (2014) Comparison of antibody responses to human papillomavirus vaccination as measured by three assays Frontiers in oncology; 328. PMID: 24455487

30. Anantharaman D., Chabrier A., Gaborieau V., Franceschi S., Herrero R., Rajkumar T., Samant T., Mahimkar M.B., Brennan P., McKay J.D. (2014) Genetic variants in nicotine addiction and alcohol metabolism genes, oral cancer risk and the propensity to smoke and drink alcohol: a replication study in India PLoS ONE; 9(2):e88240. PMID: 24505444

31. De Vuyst H., Mugo N.R., Franceschi S., McKenzie K., Tenet V., Njoroge J., Rana F.S., Sakr S.R., Snijders P.J., Chung M.H. (2014) Residual Disease and HPV Persistence after Cryotherapy for Cervical Intraepithelial Neoplasia Grade 2/3 in HIV-Positive Women in Kenya PLoS ONE; 9(10):e111037. PMID: 25343563

32. Robbins H.A., Li Y., Porras C., Pawlita M., Ghosh A., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T.J., Gonzalez P., Schiller J., Lowy D., Esser M., Matys K., Quint W., Van Doorn L.J., Herrero R., Pinto L.A., Hildesheim A., Waterboer T., Safaeian M. (2014) Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus BMC.Infect Dis; 120. PMID: 24588945

33. Guevara E., Baena A., Almonte M., Salaza J.E., Gaviria A., Sanchez G.I. (2014) Revista Facultad Nacional de Salud Publica; 32(2):54-60.

34. Robbins H.A., Waterboer T., Porras C., Kemp T.J., Pawlita M., Rodriguez A.C., Wacholder S., Gonzalez P., Schiller J.T., Lowy D.R., Esser M., Matys K., Poncelet S., Herrero R., Hildesheim A., Pinto L.A., Safaeian M. (2014) Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay Hum.Vaccin.Immunother.; 10(10):2965-2974. PMID: 25483632

35. Park J.Y., Forman D., Greenberg E.R., Herrero R. (2013) Helicobacter pylori Eradication in the Prevention of Gastric Cancer: Are More Trials Needed? Curr Oncol Rep.; 15(6):517-525. PMID: 24101366

36. Safaeian M., Porras C., Pan Y., Kreimer A., Schiller J.T., Gonzalez P., Lowy D.R., Wacholder S., Schiffman M., Rodriguez A.C., Herrero R., Kemp T., Shelton G., Quint W., Van Doorn L.J., Hildesheim A., Pinto L.A. (2013) Durable antibody responses following one dose of the bivalent human papillomavirus l1 virus-like particle vaccine in the costa rica vaccine trial Cancer Prev Res.(Phila); 6(11):1242-1250. PMID: 24189371

37. Lang Kuhs K.A., Gonzalez P., Struijk L., Castro F., Hildesheim A., Van Doorn L.J., Rodriguez A.C., Schiffman M., Quint W., Lowy D.R., Porras C., DelVecchio C., Katki H.A., Jimenez S., Safaeian M., Schiller J., Solomon D., Wacholder S., Herrero R., Kreimer A.R. (2013) Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica J Infect.Dis.; 208(10):1643-1652. PMID: 24014882

38. Rodriguez A.C., Solomon D., Herrero R., Hildesheim A., Gonzalez P., Wacholder S., Porras C., Jimenez S., Schiffman M. (2013) Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment Am.J Epidemiol; 178(5):752-760. PMID: 23843026

39. De Vuyst H., Chung M.H., Baussano I., Mugo N.R., Tenet V., van Kemenade F.J., Rana F.S., Sakr S.R., Meijer C.J., Snijders P.J., Franceschi S. (2013) Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIV-positive women in Kenya Int.J Cancer; 133(6):1441-1446. PMID: 23444059

40. Safaeian M., Kemp T.J., Pan D.Y., Porras C., Rodriguez A.C., Schiffman M., Cortes B., Katki H., Wacholder S., Schiller J.T., Gonzalez P., Penrose K., Lowy D.R., Quint W., Van Doorn L.J., Herrero R., Hildesheim A., Pinto L.A. (2013) Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial Hum Vaccin.Immunother.; 9(7):1399-1406. PMID: 23571174

41. Morgan D.R., Torres J., Sexton R., Herrero R., Salazar-Martinez E., Greenberg E.R., Bravo L.E., Dominguez R.L., Ferreccio C., Lazcano-Ponce E.C., Meza-Montenegro M.M., Pena E.M., Pena R., Correa P., Martinez M.E., Chey W.D., Valdivieso M., Anderson G.L., Goodman G.E., Crowley J.J., Baker L.H. (2013) Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities JAMA; 309(6):578-586. PMID: 23403682

42. Porras C., Nodora J., Sexton R., Ferreccio C., Jimenez S., Dominguez R.L., Cook P., Anderson G., Morgan D.R., Baker L.H., Greenberg E.R., Herrero R. (2013) Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701) Cancer causes & control : CCC; 24(2):209-215. PMID: 23263777

43. Torres J., Correa P., Ferreccio C., Hernandez-Suarez G., Herrero R., Cavazza-Porro M., Dominguez R., Morgan D. (2013) Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America Cancer causes & control : CCC; 24(2):249-256. PMID: 23224271

44. Nascimento C., De Vuyst H. (2013) Prevalence and type distribution of HPV in carcinoma and intraepithelial neoplasia of the vulva and vagina: a meta-analysis HPV Today; 12-13.

45. Herrero R., Quint W., Hildesheim A., Gonzalez P., Struijk L., Katki H.A., Porras C., Schiffman M., Rodriguez A.C., Solomon D., Jimenez S., Schiller J.T., Lowy D.R., Van Doorn L.J., Wacholder S., Kreimer A.R. (2013) Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica PLoS ONE; 8(7):e68329. PMID: 23873171

46. Herrero R. (2013) HPV and Cervical Cancer ; .

47. Lin S.W., Ghosh A., Porras C., Markt S.C., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T.J., Pinto L.A., Gonzalez P., Wentzensen N., Esser M.T., Matys K., Meuree A., Quint W., Van Doorn L.J., Herrero R., Hildesheim A., Safaeian M. (2013) HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays PLoS ONE; 8(1):e53067. PMID: 23301022

48. Bedoya A.M., Jaramillo R., Baena A., Castano J., Olaya N., Zea A.H., Herrero R., Sanchez G.I. (2013) Location and Density of Immune Cells in Precursor Lesions and Cervical Cancer Cancer Microenviron.; 6(1):69-77. PMID: 22290207

49. Gonzalez P., Cortes B., Quint W., Kreimer A.R., Porras C., Rodriguez A.C., Jimenez S., Herrero R., Struijk L., Hildesheim A., Melchers W. (2012) Evaluation of the FTA carrier device for human papillomavirus testing in developing countries Journal of clinical microbiology; 50(12):3870-3876. PMID: 22993174

50. Kemp T.J., Safaeian M., Hildesheim A., Pan Y., Penrose K.J., Porras C., Schiller J.T., Lowy D.R., Herrero R., Pinto L.A. (2012) Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix((R)) Vaccine; 31(1):165-170. PMID: 23123024

51. Li Q., Chuang S.C., Eluf-Neto J., Menezes A., Matos E., Koifman S., Wunsch-Filho V., Fernandez L., Daudt A.W., Curado M.P., Winn D.M., Franceschi S., Herrero R., Castellsague X., Morgenstern H., Zhang Z.F., Lazarus P., Muscat J., McClean M., Kelsey K.T., Hayes R.B., Purdue M.P., Schwartz S.M., Chen C., Benhamou S., Olshan A.F., Yu G., Schantz S., Ferro G., Brennan P., Boffetta P., Hashibe M. (2012) Vitamin or mineral supplement intake and the risk of head and neck cancer: pooled analysis in the INHANCE consortium International journal of cancer; 131(7):1686-1699. PMID: 22173631

52. Rodriguez A.C., Schiffman M., Herrero R., Hildesheim A., Bratti C., Sherman M.E., Solomon D., Guillen D., Alfaro M., Morales J., Hutchinson M., Cheung L., Wacholder S., Burk R.D. (2012) Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3 International journal of cancer; 131(8):1874-1881. PMID: 22213126

53. Castro F.A., Quint W., Gonzalez P., Katki H.A., Herrero R., Van Doorn L.J., Schiffman M., Struijk L., Rodriguez A.C., Del Vecchio C., Lowy D.R., Porras C., Jimenez S., Schiller J., Solomon D., Wacholder S., Hildesheim A., Kreimer A.R. (2012) Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica Journal of infectious diseases; 206(7):1103-1110. PMID: 22850119

54. Safaeian M., Ghosh A., Porras C., Lin S.W., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T., Gonzalez P., Wentzensen N., Esser M., Meuree A., Matys K., Quint W., Van Doorn L.J., Sherman M.E., Herrero R., Pinto L.A., Hildesheim A. (2012) Direct Comparison of HPV16 Serological Assays Used to Define HPV-Naive Women in HPV Vaccine Trials Cancer epidemiology, biomarkers & prevention; 21(9):1547-1554. PMID: 22752082

55. Santesso N., Schunemann H., Blumenthal P., De Vuyst H., Gage J., Garcia F., Jeronimo J., Lu R., Luciani S., Quek S.C., Awad T., Broutet N. (2012) World Health Organization Guidelines: Use of cryotherapy for cervical intraepithelial neoplasia International journal of gynaecology and obstetrics; 118(2):97-102. PMID: 22727415

56. Kreimer A.R., Schiffman M., Herrero R., Hildesheim A., Gonzalez P., Burk R.D., Porras C., Sherman M.E., Demuth F., Cheung L., Bratti C., Cecilia Rodriguez A. (2012) Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment International journal of cancer; 131(1):211-218. PMID: 21823117

57. Kemp T.J., Safaeian M., Miner S., Williams M.C., Rodriguez A.C., Herrero R., Hildesheim A., Pinto L.A. (2012) Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin Levels Frontiers in oncology; 61. PMID: 22737669